Higher-Risk Myelodysplastic Syndromes | Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes

Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman, including the following topics:

• Introduction (00:00)
• Biology of Acute Myeloid Leukemia/Myelodysplastic Syndromes (3:14)
• Assessment of Risk Status (14:17)
• Oral Hypomethylating Agents (HMAs) (22:24)
• HMA/Venetoclax; Other Combinations (31:26)
• Magrolimab/TP53 (45:12)

CME information and select publications